OPIOID GUIDELINES: THE GOOD, THE BAD, AND THE UGLY - LIVE
September 29, 2022 - The Ritz-Carlton, Rancho Mirage - Rancho Mirage, California
The workshop will provide a brief review of the history leading up to the opioid epidemic. Topics will cover the 2016 CDC guidelines, subsequent repercussion, and rationale for proposed guideline changes in 2022. The current scope of opioid use disorder in the US, as well as, the current state of Medications for Opioid Use Disorder.
This topic is important and has become a more visible public health issue. All fields within medicine that provide direct patient care are impacted, including medical, surgical and outpatient settings. All providers who prescribe (MD, DO, NP, PA, CNS) or administer (nurse, pharmacist, etc.) opioids to patients would benefit from attending this course. This course is particularly relevant for primary care providers that maintain and monitor patients on chronic opioid therapy.
Upon completion of this activity, participants should be able to:
- Compare & contrast 2016 CDC opioid prescribing guidelines with current proposed guidelines in 2022
- Apply current guideline recommendations to practice in patients across the lifespan
- Demonstrate the pitfalls and potential repercussions related to guideline application
- Review the challenges involved in chronic opioid management: balancing patient safety, patient’s quality of life, and provider satisfaction
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
All travel and lodging expenses are the sole responsibility of the individual registrant.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this other activity (live and livestream) for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|Thursday (Optional Pre-Course)||2.00|
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 2.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 2.00 knowledge-based contact hours. Participants should only claim credit commensurate with the extent of their participation in the activity.
Universal Activity Number (UAN): JA0000238-0000-22-033-L01-P
The AAFP has reviewed Mayo Clinic Opioid Conference: Evidence, Clinical Considerations, and Best Practice 2022 and deemed it acceptable for up to 15.75 Live AAFP Prescribed credits. Term of Approval is from 09/29/2022 to 10/01/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
- 2.00 AAFP Prescribed
- 2.00 ACPE
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
- 2.00 Attendance